Literature DB >> 19208352

Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction.

Erik Kirk1, Dominic N Reeds, Brian N Finck, S Mitra Mayurranjan, Mitra S Mayurranjan, Bruce W Patterson, Samuel Klein.   

Abstract

BACKGROUND & AIMS: We determined the effects of acute and chronic calorie restriction with either a low-fat, high-carbohydrate (HC) diet or a low-carbohydrate (LC) diet on hepatic and skeletal muscle insulin sensitivity.
METHODS: Twenty-two obese subjects (body mass index, 36.5 +/- 0.8 kg/m2) were randomized to an HC (>180 g/day) or LC (<50 g/day) energy-deficit diet. A euglycemic-hyperinsulinemic clamp, muscle biopsy specimens, and magnetic resonance spectroscopy were used to determine insulin action, cellular insulin signaling, and intrahepatic triglyceride (IHTG) content before, after 48 hours, and after approximately 11 weeks (7% weight loss) of diet therapy.
RESULTS: At 48 hours, IHTG content decreased more in the LC than the HC diet group (29.6% +/- 4.8% vs 8.9% +/- 1.4%; P < .05) but was similar in both groups after 7% weight loss (LC diet, 38.0% +/- 4.5%; HC diet, 44.5% +/- 13.5%). Basal glucose production rate decreased more in the LC than the HC diet group at 48 hours (23.4% +/- 2.2% vs 7.2% +/- 1.4%; P < .05) and after 7% weight loss (20.0% +/- 2.4% vs 7.9% +/- 1.2%; P < .05). Insulin-mediated glucose uptake did not change at 48 hours but increased similarly in both groups after 7% weight loss (48.4% +/- 14.3%; P < .05). In both groups, insulin-stimulated phosphorylation of c-Jun-N-terminal kinase decreased by 29% +/- 13% and phosphorylation of Akt and insulin receptor substrate 1 increased by 35% +/- 9% and 36% +/- 9%, respectively, after 7% weight loss (all P < .05).
CONCLUSIONS: Moderate calorie restriction causes temporal changes in liver and skeletal muscle metabolism; 48 hours of calorie restriction affects the liver (IHTG content, hepatic insulin sensitivity, and glucose production), whereas moderate weight loss affects muscle (insulin-mediated glucose uptake and insulin signaling).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19208352      PMCID: PMC2677125          DOI: 10.1053/j.gastro.2009.01.048

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  43 in total

1.  FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis.

Authors:  Guenther Boden; Peter Cheung; T Peter Stein; Karen Kresge; Maria Mozzoli
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-07       Impact factor: 4.310

2.  The Michigan alcoholism screening test: the quest for a new diagnostic instrument.

Authors:  M L Selzer
Journal:  Am J Psychiatry       Date:  1971-06       Impact factor: 18.112

3.  Heated hand vein blood is satisfactory for measurements during free fatty acid kinetic studies.

Authors:  M D Jensen; V J Heiling
Journal:  Metabolism       Date:  1991-04       Impact factor: 8.694

4.  Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.

Authors:  D R Matthews; J P Hosker; A S Rudenski; B A Naylor; D F Treacher; R C Turner
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

5.  Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance.

Authors:  L C Groop; R C Bonadonna; S DelPrato; K Ratheiser; K Zyck; E Ferrannini; R A DeFronzo
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

6.  Separate contribution of diabetes, total fat mass, and fat topography to glucose production, gluconeogenesis, and glycogenolysis.

Authors:  Amalia Gastaldelli; Yoshinori Miyazaki; Maura Pettiti; Emma Buzzigoli; Srikanth Mahankali; Ele Ferrannini; Ralph A DeFronzo
Journal:  J Clin Endocrinol Metab       Date:  2004-08       Impact factor: 5.958

Review 7.  Benefits and limitations of very-low-calorie diet therapy in obese NIDDM.

Authors:  R R Henry; B Gumbiner
Journal:  Diabetes Care       Date:  1991-09       Impact factor: 19.112

8.  Lipolysis during fasting. Decreased suppression by insulin and increased stimulation by epinephrine.

Authors:  M D Jensen; M W Haymond; J E Gerich; P E Cryer; J M Miles
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

9.  Effects of 3 days of "postoperative" low caloric feeding with or without bed rest on insulin sensitivity in healthy subjects.

Authors:  M Svanfeldt; A Thorell; K Brismar; J Nygren; O Ljungqvist
Journal:  Clin Nutr       Date:  2003-02       Impact factor: 7.324

10.  Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates.

Authors:  D T Finegood; R N Bergman; M Vranic
Journal:  Diabetes       Date:  1987-08       Impact factor: 9.461

View more
  148 in total

1.  Surgical removal of omental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults.

Authors:  Elisa Fabbrini; Robyn A Tamboli; Faidon Magkos; Pamela A Marks-Shulman; Aaron W Eckhauser; William O Richards; Samuel Klein; Naji N Abumrad
Journal:  Gastroenterology       Date:  2010-05-07       Impact factor: 22.682

Review 2.  Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.

Authors:  C Dirksen; N B Jørgensen; K N Bojsen-Møller; S H Jacobsen; D L Hansen; D Worm; J J Holst; S Madsbad
Journal:  Diabetologia       Date:  2012-04-27       Impact factor: 10.122

3.  Hepatobiliary quiz-3 (2012).

Authors:  Swastik Agrawal; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2012-09

Review 4.  Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials.

Authors:  G Musso; M Cassader; F Rosina; R Gambino
Journal:  Diabetologia       Date:  2012-01-27       Impact factor: 10.122

Review 5.  What is the best diet for cardiovascular wellness? A comparison of different nutritional models.

Authors:  Silvia Migliaccio; Caterina Brasacchio; Francesca Pivari; Ciro Salzano; Luigi Barrea; Giovanna Muscogiuri; Silvia Savastano; Annamaria Colao
Journal:  Int J Obes Suppl       Date:  2020-07-20

6.  Elevation of alanine transaminase and markers of liver fibrosis after a mixed meal challenge in individuals with type 2 diabetes.

Authors:  E Y H Khoo; M C Stevenson; E Leverton; R Cross; J W Eriksson; S M Poucher; I Spendlove; P G Morris; I A Macdonald; P Mansell; G P Aithal
Journal:  Dig Dis Sci       Date:  2012-05-17       Impact factor: 3.199

7.  Pre-operative dietary restriction for patients undergoing bariatric surgery in the UK: observational study of current practice and dietary effects.

Authors:  Emma L Baldry; Paul C Leeder; Iskandar R Idris
Journal:  Obes Surg       Date:  2014-03       Impact factor: 4.129

8.  Effects of Moderate and Subsequent Progressive Weight Loss on Metabolic Function and Adipose Tissue Biology in Humans with Obesity.

Authors:  Faidon Magkos; Gemma Fraterrigo; Jun Yoshino; Courtney Luecking; Kyleigh Kirbach; Shannon C Kelly; Lisa de Las Fuentes; Songbing He; Adewole L Okunade; Bruce W Patterson; Samuel Klein
Journal:  Cell Metab       Date:  2016-02-22       Impact factor: 27.287

Review 9.  Nonalcoholic fatty liver disease: current issues and novel treatment approaches.

Authors:  Romina Lomonaco; Nishanth E Sunny; Fernando Bril; Kenneth Cusi
Journal:  Drugs       Date:  2013-01       Impact factor: 9.546

Review 10.  Implications of diet on nonalcoholic fatty liver disease.

Authors:  Shelby Sullivan
Journal:  Curr Opin Gastroenterol       Date:  2010-03       Impact factor: 3.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.